HU9201966D0 - An improved vaccine of meningococcus-polysaccharide conjunction - Google Patents

An improved vaccine of meningococcus-polysaccharide conjunction

Info

Publication number
HU9201966D0
HU9201966D0 HU9201966A HU196690A HU9201966D0 HU 9201966 D0 HU9201966 D0 HU 9201966D0 HU 9201966 A HU9201966 A HU 9201966A HU 196690 A HU196690 A HU 196690A HU 9201966 D0 HU9201966 D0 HU 9201966D0
Authority
HU
Hungary
Prior art keywords
meningococcus
polysaccharide
conjunction
improved vaccine
vaccine
Prior art date
Application number
HU9201966A
Other languages
English (en)
Inventor
Harold J Jennings
Francis Michon
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of HU9201966D0 publication Critical patent/HU9201966D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HU9201966A 1989-12-14 1990-12-13 An improved vaccine of meningococcus-polysaccharide conjunction HU9201966D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44819589A 1989-12-14 1989-12-14

Publications (1)

Publication Number Publication Date
HU9201966D0 true HU9201966D0 (en) 1992-10-28

Family

ID=23779371

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9201966A HU9201966D0 (en) 1989-12-14 1990-12-13 An improved vaccine of meningococcus-polysaccharide conjunction
HU9201966A HU218146B (hu) 1989-12-14 1990-12-13 Továbbfejlesztett meningokokkusz-poliszacharid-konjugátum vakcina

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9201966A HU218146B (hu) 1989-12-14 1990-12-13 Továbbfejlesztett meningokokkusz-poliszacharid-konjugátum vakcina

Country Status (30)

Country Link
US (3) US5576002A (hu)
EP (1) EP0504202B1 (hu)
JP (1) JP2637845B2 (hu)
KR (1) KR0158436B1 (hu)
CN (4) CN1049223C (hu)
AR (1) AR243934A1 (hu)
AT (1) ATE121947T1 (hu)
AU (1) AU641715B2 (hu)
BR (1) BR9007917A (hu)
CA (1) CA2071811C (hu)
CZ (1) CZ283530B6 (hu)
DE (1) DE69019164T2 (hu)
DK (1) DK0504202T3 (hu)
ES (1) ES2071288T3 (hu)
FI (2) FI104539B (hu)
HR (1) HRP920872A2 (hu)
HU (2) HU9201966D0 (hu)
IE (1) IE68414B1 (hu)
IL (1) IL96676A (hu)
IN (1) IN171747B (hu)
NO (2) NO305275B1 (hu)
NZ (1) NZ236471A (hu)
PH (1) PH30305A (hu)
PL (2) PL166659B1 (hu)
RO (1) RO111416B1 (hu)
RU (1) RU2105568C1 (hu)
SI (1) SI20008B (hu)
WO (1) WO1991008772A1 (hu)
YU (1) YU24391A (hu)
ZA (1) ZA9010065B (hu)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
AU641715B2 (en) * 1989-12-14 1993-09-30 National Research Council Of Canada Improved meningococcal polysaccharide conjugate vaccine
ES2160601T3 (es) * 1992-09-24 2001-11-16 Brigham & Womens Hospital Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
EP1090642B8 (en) * 1995-06-07 2010-08-11 GlaxoSmithKline Biologicals s.a. Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
US5811102A (en) 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
ATE252602T1 (de) 1996-08-27 2003-11-15 Chiron Corp Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen
ATE208629T1 (de) 1996-08-27 2001-11-15 Chiron Corp Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
EP0994723A1 (en) 1997-06-24 2000-04-26 Chiron Corporation Methods of immunizing adults using anti-meningococcal vaccine compositions
PT1630168E (pt) 1997-08-27 2011-07-20 Novartis Vaccines & Diagnostic Compostos miméticos moleculares de péptidos de meningococos do serogrupo b
ES2611464T3 (es) 1997-12-23 2017-05-09 Pfizer Ireland Pharmaceuticals Polisacárido capsular bacteriano para su uso como vacuna o para su unión a proteínas en vacunas de conjugados
NZ509986A (en) * 1998-08-19 2003-10-31 Baxter Healthcare S Immunogenic beta-propionamido-linked polysaccharide and oligosaccharide protein conjugates as vaccines
US6436653B1 (en) 1998-12-15 2002-08-20 Exiqon A/S Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
RU2322451C2 (ru) 2001-04-17 2008-04-20 Новартис Вэксинс Энд Диагностикс, Инк. Молекулярные миметики эпитопов менингококка в, которые вызывают выработку функционально активных антител
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
DK1490409T3 (da) * 2002-03-26 2009-03-23 Novartis Vaccines & Diagnostic Modificerede saccharider med forbedret stabilitet i vand
WO2004089407A2 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP4566194B2 (ja) 2003-08-12 2010-10-20 リポクセン テクノロジーズ リミテッド タンパク質の誘導体化及び結合のためのシアル酸誘導体
WO2006002402A2 (en) 2004-06-23 2006-01-05 Children's Hospital & Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
US8329184B2 (en) 2005-06-27 2012-12-11 Glaxosmithkline Biologicals S.A. Process for manufacturing vaccines
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
GB0611914D0 (en) 2006-06-15 2006-07-26 Teti Giuseppe Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
EP1872791A1 (en) 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
US20100189740A1 (en) * 2007-06-20 2010-07-29 Francis Michon Modified polysaccharides for conjugate vaccines
ES2664753T3 (es) 2007-12-07 2018-04-23 Glaxosmithkline Biologicals Sa Composiciones de inducción de respuestas inmunes
WO2010083477A2 (en) 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
EP2752403A1 (de) * 2013-01-08 2014-07-09 Sika Technology AG Amin für emissionsarme Epoxidharz-Produkte
WO2017031431A1 (en) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Lipidated psa compositions and methods
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
PE20191107A1 (es) * 2017-01-31 2019-08-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
AU641715B2 (en) * 1989-12-14 1993-09-30 National Research Council Of Canada Improved meningococcal polysaccharide conjugate vaccine

Also Published As

Publication number Publication date
AR243934A1 (es) 1993-09-30
ATE121947T1 (de) 1995-05-15
NO973311L (no) 1992-08-14
SI20008A (sl) 2000-02-29
WO1991008772A1 (en) 1991-06-27
BR9007917A (pt) 1992-10-20
NZ236471A (en) 1992-10-28
FI19991917A (fi) 1999-09-09
ZA9010065B (en) 1992-02-26
CA2071811A1 (en) 1991-06-15
IE904513A1 (en) 1991-06-19
RU2105568C1 (ru) 1998-02-27
IN171747B (hu) 1992-12-26
DE69019164T2 (de) 1995-09-07
RO111416B1 (ro) 1996-10-31
FI104539B (fi) 2000-02-29
CN1100656A (zh) 1995-03-29
US5902586A (en) 1999-05-11
CN1096516A (zh) 1994-12-21
JPH05505392A (ja) 1993-08-12
JP2637845B2 (ja) 1997-08-06
CN1036522C (zh) 1997-11-26
CZ628490A3 (en) 1997-12-17
DE69019164D1 (de) 1995-06-08
IL96676A0 (en) 1991-09-16
NO922316D0 (no) 1992-06-12
CA2071811C (en) 2003-11-04
NO305275B1 (no) 1999-05-03
IE68414B1 (en) 1996-06-12
NO307835B1 (no) 2000-06-05
AU641715B2 (en) 1993-09-30
IL96676A (en) 1996-09-12
CN1055541A (zh) 1991-10-23
FI922737A0 (fi) 1992-06-12
HU218146B (hu) 2000-06-28
PL166659B1 (pl) 1995-06-30
AU6898791A (en) 1991-07-18
CN1049223C (zh) 2000-02-09
US5576002A (en) 1996-11-19
PL166035B1 (pl) 1995-03-31
NO973311D0 (no) 1997-07-17
SI20008B (en) 2001-02-28
CN1100428A (zh) 1995-03-22
DK0504202T3 (da) 1995-10-02
EP0504202B1 (en) 1995-05-03
HUT64480A (en) 1994-01-28
EP0504202A1 (en) 1992-09-23
HRP920872A2 (en) 1997-06-30
NO922316L (no) 1992-08-14
PL288271A1 (en) 1991-12-16
US5683699A (en) 1997-11-04
ES2071288T3 (es) 1995-06-16
CZ283530B6 (cs) 1998-04-15
CN1072506C (zh) 2001-10-10
KR0158436B1 (ko) 1998-12-01
YU24391A (sh) 1995-12-04
PH30305A (en) 1997-02-20
CN1036504C (zh) 1997-11-26

Similar Documents

Publication Publication Date Title
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
GB8924438D0 (en) Vaccine composition
EP0454735A4 (en) Vaccine composition
EP0391997A4 (en) Vaccine
IL96306A0 (en) Preparation of deoxyfluoronucleosides
GB2228262B (en) Antigenic derivative of gnrh
GB8921470D0 (en) Vaccines
ZA902147B (en) Coccidiosis vaccine
GB8918689D0 (en) 25/15 vaccine
AP9000165A0 (en) Vaccine composition
GB8704647D0 (en) Vaccine
GB2248186B (en) Preparation of vaccines
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GB8912496D0 (en) Vaccines
ZA896372B (en) Vaccine
GB8918394D0 (en) Preparation of polyhemiacetals
EP0453452A4 (en) Vaccine
IL89362A0 (en) Preparation of tetrabromotetralin
ZA909516B (en) Novel vaccine
GB8922651D0 (en) Vaccine
GB8901549D0 (en) Antigenic derivative of gnrh
GB8907688D0 (en) Antigenic derivative of gnrh
IE894144L (en) Preparation of deglucoteicoplanin
IE893752L (en) Preparation of n-acyl-aminomethyl-phosphonates
IE892415L (en) Preparation of polyhydroxysilazanes